Outcomes

The reported outcomes for larazotide are derived from a limited evidence base consisting primarily of preclinical studies and a small number of clinical trials, with mixed results regarding efficacy.

Clinical Trial Outcomes

Clinical evidence for larazotide is notably limited. A Phase 3 trial evaluating larazotide acetate for celiac disease symptom relief was terminated (NCT03569007), though specific outcome data from this terminated study are not provided in the available evidence. An earlier Phase 2 safety and tolerability study in celiac disease subjects was completed (NCT00362856), but efficacy outcomes are not detailed in the available information.

One ongoing Phase 2 trial is investigating larazotide (AT1001) for long COVID treatment (NCT05747534), but results are not yet available.

Preclinical and Mechanistic Outcomes

Laboratory studies suggest several potential therapeutic mechanisms:

Intestinal Barrier Protection: Studies report that larazotide acetate protects intestinal mucosal barriers from anoxia/reoxygenation injury through various cellular mechanisms, though specific biomarker changes or quantitative measures are not detailed in the available evidence.

Anti-inflammatory Effects: Research indicates larazotide may have preventive effects on non-alcoholic fatty liver disease (NAFLD) in mouse models and potential benefits in colitis when delivered via sustained-release hydrogel formulations.

Post-Viral Recovery: One study reported "viral spike antigen clearance and augmented recovery" in children with post-COVID multisystem inflammatory syndrome treated with larazotide, suggesting potential immunomodulatory effects.

Evidence Limitations

The strength of evidence for larazotide's clinical efficacy remains weak to moderate. The termination of the Phase 3 celiac disease trial raises questions about the compound's therapeutic benefit in its primary indication. Most reported outcomes come from preclinical studies or case reports rather than controlled clinical trials, limiting the ability to draw definitive conclusions about clinical effectiveness.

This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers for personalized treatment recommendations.

Larazotide

Member access required